ArticleResearch (Washington, D.C.)2022

Targeting Aberrant Histone Posttranscription Modification Machinery in Esophageal Squamous Cell Carcinoma: Current Findings and Challenges.

Gang Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.